Overexpression of KLF4 Suppresses Pulmonary Fibrosis through the HIF-1α/Endoplasmic Reticulum Stress Signaling Pathway
-
Published:2023-09-12
Issue:18
Volume:24
Page:14008
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Wei Shanchen1, Qi Fei2, Wu Yanping3, Liu Xinmin1
Affiliation:
1. Department of Geriatric, Peking University First Hospital, Beijing 100034, China 2. School Of Clinical Medicine, Anhui Medical College, Hefei 230032, China 3. Department of Chemotherapy, Peking University First Hospital, Beijing 100034, China
Abstract
The hypoxia-inducible factor-1α/endoplasmic reticulum stress signaling pathway (HIF-1α/ERS) has a crucial role in the pathogenetic mechanism of pulmonary fibrosis (PF). However, the upstream regulatory mediators of this pathway remain unclear. In the present study, by conducting bioinformatics analysis, we found that Krüppel-like factor 4 (KLF4) expression was decreased in the lung tissues of patients with idiopathic pulmonary fibrosis (IPF) as compared to that in patients with non-IPF. Furthermore, KLF4 expression was significantly reduced (p = 0.0331) in bleomycin-induced fibrotic HFL-1 cells. Moreover, in mice with bleomycin-induced PF, the degree of fibrosis was significantly reduced in mice overexpressing KLF4 as compared to that in wild-type mice. In mice and HFL-1 cells, KLF4 overexpression significantly reduced bleomycin-induced protein expression of HIF-1α (p = 0.0027) and ERS markers, particularly p-IRE1α (p = 0.0255) and ATF6 (p = 0.0002). By using the JASPAR database, we predicted that KLF4 has five binding sites for the HIF-1α promoter. The results of in vitro and in vivo studies suggest that KLF4 may inhibit PF through the HIF-1α/ERS pathway. This finding could guide the development of future therapies for PF and facilitate the identification of appropriate biomarkers for routine clinical diagnosis of PF.
Funder
National Natural Science Foundation of China
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference34 articles.
1. Idiopathic Pulmonary Fibrosis;Lederer;N. Engl. J. Med.,2018 2. New treatment directions for IPF: Current status of ongoing and upcoming clinical trials;Macagno;Expert Rev. Respir. Med.,2017 3. Baratella, E., Ruaro, B., Giudici, F., Wade, B., Santagiuliana, M., Salton, F., Confalonieri, P., Simbolo, M., Scarpa, A., and Tollot, S. (2021). Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary Fibrosis. Diagnostics, 11. 4. What have we learned from basic science studies on idiopathic pulmonary fibrosis?;Yanagihara;Eur. Respir. Rev.,2019 5. Calabrese, F., Lunardi, F., Tauro, V., Pezzuto, F., Fortarezza, F., Vedovelli, L., Faccioli, E., Balestro, E., Schiavon, M., and Esposito, G. (2022). RNA Sequencing of Epithelial Cell/Fibroblastic Foci Sandwich in Idiopathic Pulmonary Fibrosis: New Insights on the Signaling Pathway. Int. J. Mol. Sci., 23.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|